FDA, DOJ Scrutiny Hurts St. Jude’s Earnings, Pipeline Development

A Justice Department investigation and changing endpoint requirements at the FDA are negatively impacting St. Jude Medical’s expectations for its cardiac rhythm management (CRM) and neuromodulation divisions.
Devices & Diagnostics Letter